The point of care devices market size has grown strongly in recent years. It will grow from $31.46 billion in 2025 to $34.44 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to limited access to centralized laboratories, growing burden of chronic diseases, need for faster clinical decision making, expansion of primary healthcare facilities, rising demand for bedside diagnostics.
The point of care devices market size is expected to see strong growth in the next few years. It will grow to $48.88 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to advancements in microfluidics and biosensors, increasing adoption of wearable and remote monitoring devices, growth in home healthcare settings, rising infectious disease surveillance needs, integration of digital health platforms. Major trends in the forecast period include rising adoption of rapid diagnostic testing at care sites, increasing demand for home-based and self-testing devices, miniaturization of diagnostic and monitoring devices, growing focus on decentralized healthcare delivery, expansion of point of care testing in emergency and critical care.
The rising demand for diagnostic imaging is expected to drive the growth of the point-of-care devices market in the coming years. Diagnostic imaging encompasses techniques used to create visual representations of the body’s interior for clinical evaluation and medical intervention. This demand is increasing due to the growing prevalence of chronic diseases that require early and accurate diagnosis. Point-of-care devices support diagnostic imaging by offering compact, portable designs suitable for clinics, bedside use, and remote healthcare settings. They improve clinical efficiency by delivering rapid and accurate imaging results, enabling timely decision-making and enhanced patient care. For example, in November 2024, the National Health Service (NHS), a UK-based government agency, reported 47.2 million imaging tests in England for the year ending March 2024, up 4.8% from 45 million in the previous year. Consequently, the growing demand for diagnostic imaging is fueling the growth of the point-of-care devices market.
Key players in the point-of-care devices market are developing advanced solutions such as AI-powered handheld ultrasound systems to enhance diagnostic accuracy and portability. These systems are portable imaging devices that leverage artificial intelligence algorithms to assist in capturing and interpreting ultrasound images, enabling faster and more accurate diagnoses. For instance, in October 2023, Koninklijke Philips N.V., a Netherlands-based healthcare technology company, launched the Compact 5000 Series, an AI-enhanced point-of-care ultrasound system. This portable device delivers high-quality imaging combined with AI-driven automation for measurements and streamlined workflows, enabling rapid and precise diagnostics across diverse healthcare settings. It features intuitive controls, supports multiple transducers, and integrates seamlessly with telemedicine platforms to facilitate collaborative remote patient care.
In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired the point-of-care technology platform from LumiraDx Limited for an undisclosed amount. This acquisition aims to strengthen Roche’s presence in decentralized diagnostics by integrating a user-friendly, portable platform capable of performing immunochemistry and clinical chemistry tests, with potential for future molecular diagnostics. LumiraDx Limited is a UK-based diagnostics company specializing in point-of-care devices.
Major companies operating in the point of care devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Hologic Inc., BioMérieux SA, Quidel Corporation, OraSure Technologies Inc., Nova Biomedical Corporation, Sekisui Diagnostics LLC, Abaxis Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Chembio Diagnostics Inc., PTS Diagnostics LLC, MeMed, Alere Inc., Diagnostics For All Inc.
North America was the largest region in the point of care devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point of care devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the point of care devices market by increasing costs for imported electronic components, sensors, and microfluidic cartridges used in diagnostic and monitoring devices. Segments such as molecular diagnostics, wearable monitoring devices, and nucleic acid testing are most affected, particularly in Asia-Pacific manufacturing hubs like China and Southeast Asia. These tariffs have led to higher device prices and supply chain restructuring. However, they have also encouraged regional manufacturing, localization of supply chains, and innovation in cost-efficient point of care technologies.
The point of care devices market research report is one of a series of new reports that provides point of care devices market statistics, including point of care devices industry global market size, regional shares, competitors with a point of care devices market share, detailed point of care devices market segments, market trends and opportunities, and any further data you may need to thrive in the point of care devices industry. This point of care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Point-of-care devices are medical diagnostic tools designed for use at or near the site of patient care, including clinics, hospitals, or even home settings. Their primary purpose is to provide rapid, on-the-spot test results, enabling timely clinical decisions and immediate treatment. These devices simplify complex laboratory tests, making healthcare more efficient and accessible.
The primary types of point-of-care devices include diagnostic devices, therapeutic devices, monitoring devices, treatment devices, and support devices. Diagnostic devices are medical instruments used to detect, measure, and monitor diseases or health conditions by analyzing patient samples or physiological parameters. They employ technologies such as biochemical assays, microfluidics, immunoassays, nucleic acid testing, and wearable technology, and are applied across fields like cardiology, diabetes management, infectious diseases, oncology, and pediatrics. These devices are distributed through channels including direct sales, distributors, online platforms, retail pharmacies, and healthcare institutions, serving end users across these same channels.
The point of care devices market consists of revenues earned by entities by providing services such as rapid diagnostic testing, decentralized patient monitoring, mobile health diagnostics, chronic disease screening, and real-time clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care devices market also includes sales of portable blood glucose meters, handheld immunoassay analyzers, rapid antigen test kits, mobile hematology analyzers, and compact molecular diagnostic devices. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The point of care devices market size is expected to see strong growth in the next few years. It will grow to $48.88 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to advancements in microfluidics and biosensors, increasing adoption of wearable and remote monitoring devices, growth in home healthcare settings, rising infectious disease surveillance needs, integration of digital health platforms. Major trends in the forecast period include rising adoption of rapid diagnostic testing at care sites, increasing demand for home-based and self-testing devices, miniaturization of diagnostic and monitoring devices, growing focus on decentralized healthcare delivery, expansion of point of care testing in emergency and critical care.
The rising demand for diagnostic imaging is expected to drive the growth of the point-of-care devices market in the coming years. Diagnostic imaging encompasses techniques used to create visual representations of the body’s interior for clinical evaluation and medical intervention. This demand is increasing due to the growing prevalence of chronic diseases that require early and accurate diagnosis. Point-of-care devices support diagnostic imaging by offering compact, portable designs suitable for clinics, bedside use, and remote healthcare settings. They improve clinical efficiency by delivering rapid and accurate imaging results, enabling timely decision-making and enhanced patient care. For example, in November 2024, the National Health Service (NHS), a UK-based government agency, reported 47.2 million imaging tests in England for the year ending March 2024, up 4.8% from 45 million in the previous year. Consequently, the growing demand for diagnostic imaging is fueling the growth of the point-of-care devices market.
Key players in the point-of-care devices market are developing advanced solutions such as AI-powered handheld ultrasound systems to enhance diagnostic accuracy and portability. These systems are portable imaging devices that leverage artificial intelligence algorithms to assist in capturing and interpreting ultrasound images, enabling faster and more accurate diagnoses. For instance, in October 2023, Koninklijke Philips N.V., a Netherlands-based healthcare technology company, launched the Compact 5000 Series, an AI-enhanced point-of-care ultrasound system. This portable device delivers high-quality imaging combined with AI-driven automation for measurements and streamlined workflows, enabling rapid and precise diagnostics across diverse healthcare settings. It features intuitive controls, supports multiple transducers, and integrates seamlessly with telemedicine platforms to facilitate collaborative remote patient care.
In July 2024, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, acquired the point-of-care technology platform from LumiraDx Limited for an undisclosed amount. This acquisition aims to strengthen Roche’s presence in decentralized diagnostics by integrating a user-friendly, portable platform capable of performing immunochemistry and clinical chemistry tests, with potential for future molecular diagnostics. LumiraDx Limited is a UK-based diagnostics company specializing in point-of-care devices.
Major companies operating in the point of care devices market are Johnson & Johnson, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Hologic Inc., BioMérieux SA, Quidel Corporation, OraSure Technologies Inc., Nova Biomedical Corporation, Sekisui Diagnostics LLC, Abaxis Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Chembio Diagnostics Inc., PTS Diagnostics LLC, MeMed, Alere Inc., Diagnostics For All Inc.
North America was the largest region in the point of care devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point of care devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the point of care devices market by increasing costs for imported electronic components, sensors, and microfluidic cartridges used in diagnostic and monitoring devices. Segments such as molecular diagnostics, wearable monitoring devices, and nucleic acid testing are most affected, particularly in Asia-Pacific manufacturing hubs like China and Southeast Asia. These tariffs have led to higher device prices and supply chain restructuring. However, they have also encouraged regional manufacturing, localization of supply chains, and innovation in cost-efficient point of care technologies.
The point of care devices market research report is one of a series of new reports that provides point of care devices market statistics, including point of care devices industry global market size, regional shares, competitors with a point of care devices market share, detailed point of care devices market segments, market trends and opportunities, and any further data you may need to thrive in the point of care devices industry. This point of care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Point-of-care devices are medical diagnostic tools designed for use at or near the site of patient care, including clinics, hospitals, or even home settings. Their primary purpose is to provide rapid, on-the-spot test results, enabling timely clinical decisions and immediate treatment. These devices simplify complex laboratory tests, making healthcare more efficient and accessible.
The primary types of point-of-care devices include diagnostic devices, therapeutic devices, monitoring devices, treatment devices, and support devices. Diagnostic devices are medical instruments used to detect, measure, and monitor diseases or health conditions by analyzing patient samples or physiological parameters. They employ technologies such as biochemical assays, microfluidics, immunoassays, nucleic acid testing, and wearable technology, and are applied across fields like cardiology, diabetes management, infectious diseases, oncology, and pediatrics. These devices are distributed through channels including direct sales, distributors, online platforms, retail pharmacies, and healthcare institutions, serving end users across these same channels.
The point of care devices market consists of revenues earned by entities by providing services such as rapid diagnostic testing, decentralized patient monitoring, mobile health diagnostics, chronic disease screening, and real-time clinical decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care devices market also includes sales of portable blood glucose meters, handheld immunoassay analyzers, rapid antigen test kits, mobile hematology analyzers, and compact molecular diagnostic devices. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Point of Care Devices Market Characteristics
3. Point of Care Devices Market Supply Chain Analysis
4. Global Point of Care Devices Market Trends and Strategies
5. Point of Care Devices Market Analysis of End Use Industries
7. Global Point of Care Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Point of Care Devices Total Addressable Market (TAM) Analysis for the Market
9. Point of Care Devices Market Segmentation
10. Point of Care Devices Market Regional and Country Analysis
11. Asia-Pacific Point of Care Devices Market
12. China Point of Care Devices Market
13. India Point of Care Devices Market
14. Japan Point of Care Devices Market
15. Australia Point of Care Devices Market
16. Indonesia Point of Care Devices Market
17. South Korea Point of Care Devices Market
18. Taiwan Point of Care Devices Market
19. South East Asia Point of Care Devices Market
20. Western Europe Point of Care Devices Market
21. UK Point of Care Devices Market
22. Germany Point of Care Devices Market
23. France Point of Care Devices Market
24. Italy Point of Care Devices Market
25. Spain Point of Care Devices Market
26. Eastern Europe Point of Care Devices Market
27. Russia Point of Care Devices Market
28. North America Point of Care Devices Market
29. USA Point of Care Devices Market
30. Canada Point of Care Devices Market
31. South America Point of Care Devices Market
32. Brazil Point of Care Devices Market
33. Middle East Point of Care Devices Market
34. Africa Point of Care Devices Market
36. Point of Care Devices Market Competitive Landscape and Company Profiles
37. Point of Care Devices Market Other Major and Innovative Companies
40. Point of Care Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Point Of Care Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses point of care devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for point of care devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type Of Device: Diagnostic Devices; Therapeutic Devices; Monitoring Devices; Treatment Devices; Support Devices2) By Technology: Biochemical Technology; Microfluidics; Immunoassay Technology; Nucleic Acid Testing; Wearable Technology
3) By Application: Cardiology; Diabetes Management; Infectious Diseases; Oncology; Pediatrics
4) By Distribution Channel: Direct Sales; Distributors; Online Sales; Retail Pharmacies; Healthcare Institutions
5) By End User: Hospitals; Clinics; Home Care Settings; Diagnostic Laboratories; Emergency Medical Services (EMS)
Subsegments:
1) By Diagnostic Devices: Blood Glucose Monitors; Hematology Analyzers; Coagulation Analyzers; Urinalysis Devices; Molecular Diagnostics2) By Therapeutic Devices: Infusion Pumps; Respiratory Therapy Devices; Pain Management Devices; Wound Care Devices; Dialysis Devices
3) By Monitoring Devices: Vital Signs Monitors; Cardiac Monitors; Pulse Oximeters; Temperature Monitors; Respiratory Monitors
4) By Treatment Devices: Defibrillators; Surgical Devices; Laser Therapy Devices; Physical Therapy Devices
5) By Support Devices: Sample Collection Devices; Specimen Transport Devices; Data Management Devices; Calibration And Maintenance Devices
Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; Hologic Inc.; BioMérieux SA; Quidel Corporation; OraSure Technologies Inc.; Nova Biomedical Corporation; Sekisui Diagnostics LLC; Abaxis Inc.; EKF Diagnostics Holdings plc; Trinity Biotech plc; Chembio Diagnostics Inc.; PTS Diagnostics LLC; MeMed; Alere Inc.; Diagnostics For All Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Point of Care Devices market report include:- Johnson & Johnson
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers AG
- Becton Dickinson and Company
- Hologic Inc.
- BioMérieux SA
- Quidel Corporation
- OraSure Technologies Inc.
- Nova Biomedical Corporation
- Sekisui Diagnostics LLC
- Abaxis Inc.
- EKF Diagnostics Holdings plc
- Trinity Biotech plc
- Chembio Diagnostics Inc.
- PTS Diagnostics LLC
- MeMed
- Alere Inc.
- Diagnostics For All Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 34.44 Billion |
| Forecasted Market Value ( USD | $ 48.88 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
